We investigated the cationic dinuclear Pt(II) complex AMPZ ([{cis-Pt(NH3)2}2(Ό-OH)(Ό-pyrazolato)](NO3)2) as a tool for constructing biolog Show more
We investigated the cationic dinuclear Pt(II) complex AMPZ ([{cis-Pt(NH3)2}2(Ό-OH)(Ό-pyrazolato)](NO3)2) as a tool for constructing biological metal-organic frameworks (bio-MOFs) via liquid-liquid phase separation (LLPS). AMPZ efficiently induced LLPS in 44- or 45-mer single-stranded DNA (ssDNA) fragments, generating droplets whose properties depended on the relative abundance of nucleobase and the presence or absence of coordination interactions with AMPZ. In guanine-rich ssDNA, AMPZ promoted droplet gelation through cross-linking and formation of a coordination-bonded network, whereas adenine-rich, guanine-deficient ssDNA did not undergo gelation. 1H nuclear magnetic resonance analysis of reactions between AMPZ and mononucleosides or mononucleotides revealed that nucleobase-dependent differences in droplet properties arise from distinct reaction mechanisms and kinetics. Notably, AMPZ and adenine form a unique 1:1 complex in which the N7 nitrogen and deprotonated N6-NH of adenine coordinate to the two Pt(II) ions of AMPZ, forming an eight-membered chelate. This chelate prevents cross-linking of adenine-rich ssDNA and the subsequent gel transition. AMPZ and cytosine also provide a similar 1:1 chelate complex. These findings demonstrate that AMPZ modulates droplet formation and properties in a nucleobase-dependent manner. The mechanistic insights uncovered here provide a new strategy for constructing bio-MOFs via LLPS, exploiting the two-step interactions between AMPZ and DNA. Show less
Coacervates are dense aqueous phases that form by liquid-liquid phase separation. Seven Pt(II) complexes with different charges and nucleotide reactivities were examined for their ability to induce co Show more
Coacervates are dense aqueous phases that form by liquid-liquid phase separation. Seven Pt(II) complexes with different charges and nucleotide reactivities were examined for their ability to induce coacervate formation in a 21-mer single-stranded DNA (ssDNA). Only AMPZ ([cis-{Pt(NH3)2}2(ÎŒ-pyrazolato)(ÎŒ-OH)](NO3)2), a cationic dinuclear Pt(II) complex, efficiently induced coacervate formation in ssDNA containing only thymine (T21-DNA). AMPZ has very low reactivity with thymine but relatively high reactivity with guanine, and when three of the thymines in T21-DNA were substituted with a guanine to produce T18-G3-DNA, the resulting coacervate was observed to undergo gelation via the formation of an extensive Pt-DNA coordination-bonded network. We then examined the construction of coacervates that comprise multiple phases by adding AMPZ to a mixture of two types of ssDNAs, a highly reactive T10-G11-DNA and a minimally reactive T21-DNA, and found that two distinct assembly statesâa cell mimetic assembly and a DNA-encapsulating gelâcould be formed. Show less
Mitochondria are central actors in diverse physiological phenomena ranging from energy metabolism to stress signaling and immune modulation. Accumulating scientific evidence points to the critical inv Show more
Mitochondria are central actors in diverse physiological phenomena ranging from energy metabolism to stress signaling and immune modulation. Accumulating scientific evidence points to the critical involvement of specific mitochondrial-associated events, including mitochondrial quality control, intercellular mitochondrial transfer, and mitochondrial genetics, in potentiating the metastatic cascade of neoplastic cells. Furthermore, numerous recent studies have consistently emphasized the highly significant role mitochondria play in coordinating the regulation of tumor-infiltrating immune cells and immunotherapeutic interventions. This review provides a comprehensive and rigorous scholarly investigation of this subject matter, exploring the intricate mechanisms by which mitochondria contribute to tumor metastasis and examining the progress of mitochondria-targeted cancer therapies. Show less
Colorectal cancer (CRC) is the third most common cancer worldwide, and the second most common cause of cancer-related death. In 2020, the estimated number of deaths due to CRC was approximately 930000 Show more
Colorectal cancer (CRC) is the third most common cancer worldwide, and the second most common cause of cancer-related death. In 2020, the estimated number of deaths due to CRC was approximately 930000, accounting for 10% of all cancer deaths worldwide. Accordingly, there is a vast amount of ongoing research aiming to find new and improved treatment modalities for CRC that can potentially increase survival and decrease overall morbidity and mortality. Current management strategies for CRC include surgical procedures for resectable cases, and radiotherapy, chemotherapy, and immunotherapy, in addition to their combination, for non-resectable tumors. Despite these options, CRC remains incurable in 50% of cases. Nonetheless, significant improvements in research techniques have allowed for treatment approaches for CRC to be frequently updated, leading to the availability of new drugs and therapeutic strategies. This review summarizes the most recent therapeutic approaches for CRC, with special emphasis on new strategies that are currently being studied and have great potential to improve the prognosis and lifespan of patients with CRC. Show less
Developing novel therapeutics often follows three steps: target identification, design of strategies to suppress target activity and drug development to implement the strategies. In this review, we re Show more
Developing novel therapeutics often follows three steps: target identification, design of strategies to suppress target activity and drug development to implement the strategies. In this review, we recount the evidence identifying the basic leucine zipper transcription factors ATF5, CEBPB, and CEBPD as targets for brain and other malignancies. We describe strategies that exploit the structures of the three factors to create inhibitory dominant-negative (DN) mutant forms that selectively suppress growth and survival of cancer cells. We then discuss and compare four peptides (CP-DN-ATF5, Dpep, Bpep and ST101) in which DN sequences are joined with cell-penetrating domains to create drugs that pass through tissue barriers and into cells. The peptide drugs show both efficacy and safety in suppressing growth and in the survival of brain and other cancers in vivo, and ST101 is currently in clinical trials for solid tumors, including GBM. We further consider known mechanisms by which the peptides act and how these have been exploited in rationally designed combination therapies. We additionally discuss lacunae in our knowledge about the peptides that merit further research. Finally, we suggest both short- and long-term directions for creating new generations of drugs targeting ATF5, CEBPB, CEBPD, and other transcription factors for treating brain and other malignancies. Show less
Mitochondria play an important role in energy conversion as well as in intracellular calcium (Ca2+) storage. Ca2+ uptake from the cytosol to the mitochondria is mediated by the calcium uniporter, whic Show more
Mitochondria play an important role in energy conversion as well as in intracellular calcium (Ca2+) storage. Ca2+ uptake from the cytosol to the mitochondria is mediated by the calcium uniporter, which functions as a Ca2+ ion channel. However, the molecular composition of this uniporter has remained unclear until recently. The Ca2+ ion channel consists of seven subunits. The yeast reconstitution technique revealed that the mitochondrial calcium uniporter (MCU) and essential MCU regulatory element (EMRE) are the core subunits of the complex. Furthermore, detailed structure-function analyses of the core subunits (MCU and EMRE) were performed. In this review, the regulatory mechanism of mitochondrial Ca2+ uptake is discussed. Show less
The elucidation of a compound's Mechanism of Action (MoA) is a challenging task in the drug discovery process, but it is important in order to rationalise phenotypic findings and to anticipate potenti Show more
The elucidation of a compound's Mechanism of Action (MoA) is a challenging task in the drug discovery process, but it is important in order to rationalise phenotypic findings and to anticipate potential side-effects. Bioinformatic approaches, advances in machine learning techniques and the increasing deposition of high-throughput data in public databases have significantly contributed to recent advances in the field, but it is not straightforward to decide which data and methods are most suitable to use in a given case. In this review, we focus on these methods and data and their applications in generating MoA hypotheses for subsequent experimental validation. We discuss compound-specific data such as -omics, cell morphology and bioactivity data, as well as commonly used supplementary prior knowledge such as network and pathway data, and provide information on databases where this data can be accessed. In terms of methodologies, we discuss both well-established methods (connectivity mapping, pathway enrichment) as well as more developing methods (neural networks and multi-omics integration). Finally, we review case studies where the MoA of a compound was successfully suggested from computational analysis by incorporating multiple data modalities and/or methodologies. Our aim for this review is to provide researchers with insights into the benefits and drawbacks of both the data and methods in terms of level of understanding, biases and interpretation â and to highlight future avenues of investigation which we foresee will improve the field of MoA elucidation, including greater public access to -omics data and methodologies which are capable of data integration. Show less
The outcomes for relapsed and metastatic Ewing sarcoma (EWS) is extremely poor. Therefore, it is important to identify the tumor-specific targets in these intractable diseases. High focal adhesion kin Show more
The outcomes for relapsed and metastatic Ewing sarcoma (EWS) is extremely poor. Therefore, it is important to identify the tumor-specific targets in these intractable diseases. High focal adhesion kinase (FAK) transcript expression levels in EWS cell lines are known. TAE226 is a dual inhibitor of FAK and insulin-like growth factor-I receptor (IGF-IR), while PF-562,271 is a dual inhibitor of FAK and proline-rich tyrosine kinase 2. We compared the cytotoxicity of TAE226 and PF-562,271 toward three EWS cell lines. TAE226 strongly inhibited proliferation of three cell lines when compared with PF-562,271. Furthermore, we investigated the efficacy of TAE226 as well as its mechanism of action against EWS. A stable EWS cell line with FAK and IGF-IR knocked down was established, and microarray analysis revealed dysregulated expression in various pathways. TAE226 treatment of EWS cell lines induced cell cycle arrest, apoptosis, AKT dephosphorylation, and inhibition of invasion. We demonstrated that TAE226 drastically inhibits the local growth of primary tumors and metastasis in EWS using mouse models. Furthermore, the combination of TAE226 and conventional chemotherapy proved to exert synergistic effects. TAE226 may be a candidate single agent or combined therapy drug to be developed for patients who have relapse and metastatic EWS tumors in future. Show less